Efficacy and tolerability of Hairgain (R) in individuals with hair loss: Aplacebo-controlled, double-blind study

This randomized, placebo-controlled, double-blind study was designed to inv estigate the efficacy and tolerability of a new agent for the treatment of hair loss, based on a marine protein, minerals and vitamins. Sixty subjects with hair loss of different aetiologies participated in the 6-month blinde d phase of the study. Objective assessments indicated that the treatment wa s effective and subjective assessments showed a statistically significant p ositive effect of treatment. Exposure to the active preparation for a furth er 6 months in an open phase indicated a further improvement in hair growth . Exposure of the patients previously treated with placebo to the active pr eparation for 12 months gave similar results. Tolerability was good and no side-effects were reported. The product investigated may provide an alterna tive to pharmacotherapy for the treatment of hair-loss problems in individu als with androgenic alopecia.